These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5074179)

  • 21. Immune abnormalities associated with chronic mucocutaneous candidiasis.
    Valdimarsson H; Higgs JM; Wells RS; Yamamura M; Hobbs JR; Holt PJ
    Cell Immunol; 1973 Mar; 6(3):348-61. PubMed ID: 4632363
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic mucocutaneous moniliasis with impaired delayed hypersensitivity.
    Kirkpatrick CH; Chandler JW; Schimke RN
    Clin Exp Immunol; 1970 Mar; 6(3):375-85. PubMed ID: 5442521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution.
    Kirkpatrick CH; Rich RR; Graw RG; Smith TK; Mickenberg I; Rogentine GN
    Clin Exp Immunol; 1971 Dec; 9(6):733-48. PubMed ID: 4945734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diffuse chronic mucocutaneous candida mycosis in childhood--an expression of immune deficiency].
    Meinhof W; Hund G
    MMW Munch Med Wochenschr; 1975 May; 117(21):897-8. PubMed ID: 807800
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic mucocutaneous candidiasis of the adult. A report of a patient with an associated thymoma.
    Maize JC; Lynch PJ
    Arch Dermatol; 1972 Jan; 105(1):96-8. PubMed ID: 5009626
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma thymic hormone activity in patients with chronic mucocutaneous candidiasis.
    Kirkpatrick CH; Greenberg LE; Chapman SW; Goldstein G; Lewis VM; Twomey JJ
    Clin Exp Immunol; 1978 Dec; 34(3):311-7. PubMed ID: 743805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: immunological reconstitution by allogeneic bone marrow.
    Buckley RH; Lucas ZJ; Hattler BG; Zmijewski CM; Amos DB
    Clin Exp Immunol; 1968 Feb; 3(2):153-69. PubMed ID: 4171049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune reconstitution in keratoconjunctivitis and superficial candidiasis. The role of immunocompetent lymphocyte transfusion and transfer factor.
    Wong VG; Kirkpatrick CH
    Arch Ophthalmol; 1974 Oct; 92(4):335-9. PubMed ID: 4413776
    [No Abstract]   [Full Text] [Related]  

  • 29. Thymic conversion of Candida albicans from commensalism to pathogenism.
    Schoch EP
    Arch Dermatol; 1971 Mar; 103(3):311-9. PubMed ID: 5548278
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy.
    Kirkpatrick CH; Smith TK
    Ann Intern Med; 1974 Mar; 80(3):310-20. PubMed ID: 4816171
    [No Abstract]   [Full Text] [Related]  

  • 31. Altered, but not diminished specific T cell response in chronic mucocutaneous candidiasis patients.
    Eyerich K; Rombold S; Foerster S; Behrendt H; Hofmann H; Ring J; Traidl-Hoffmann C
    Arch Dermatol Res; 2007 Dec; 299(10):475-81. PubMed ID: 17960405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic mucocutaneous candidiasis.
    Lancet; 1978 May; 1(8072):1026-7. PubMed ID: 76941
    [No Abstract]   [Full Text] [Related]  

  • 33. [First experience with transfer factor therapy in chronic mucocutaneous candida mycosis].
    Westphal HJ; Kaben U; Schröder I; Jenssen HL; Köhler H; Werner H; Mix E
    Dermatol Monatsschr; 1976 Feb; 162(2):124-8. PubMed ID: 955186
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An immunological investigation of a family with chronic mucocutaneous candidiasis.
    Rothschild H; Wilson M; Lopez M; Salvaggio J; Bice D
    Int Arch Allergy Appl Immunol; 1976; 52(1-4):291-6. PubMed ID: 797672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged oral treatment of chronic mucocutaneous candidiasis with Amphotericin B.
    Montes LF; Cooper MD; Bradford LG; Lauderdale RO; Taylor CD
    Arch Dermatol; 1971 Jul; 104(1):45-56. PubMed ID: 5120161
    [No Abstract]   [Full Text] [Related]  

  • 37. The two-step leukocyte migration inhibition factor (LIF) assay. Its use in evaluation of cellular immune function in patients with immunodeficiency diseases.
    Chapman SW; Kirkpatrick CH
    Cell Immunol; 1978 Apr; 37(1):209-20. PubMed ID: 350420
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on lymphocyte and monocyte function in chronic mucocutaneous candidiasis.
    Goldberg LS; Bluestone R; Barnett EV; Landau JW
    Clin Exp Immunol; 1971 Jan; 8(1):37-43. PubMed ID: 5099755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model.
    Jorizzo JL; Sams WM; Jegasothy BV; Olansky AJ
    Ann Intern Med; 1980 Feb; 92(2 Pt 1):192-5. PubMed ID: 7352725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cellular immune defect in chronic mucocutaneous candidiasis.
    Chilgren RA; Meuwissen HJ; Quie PG; Good RA; Hong R
    Lancet; 1969 Jun; 1(7609):1286-8. PubMed ID: 4182179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.